Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hepatitis Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hepatitis Other
    Entecavir Safe, Effective in Patients Unresponsive to Lamivudine - (DGNews)
    Low-Dose Tenofovir Shows Efficacy in Patients With Lamivudine-Resistant Hepatitis B Virus: Presented at IM - (DGDispatch)
    Tenofovir Active in Previously Treated Chronic Hepatitis B, Including Adefovir-Resistant Virus: Presented at EASL - (DGDispatch)
    Adefovir Switch to Tenofovir at 48 Weeks Improves Viral Suppression in Patients With Chronic Hepatitis B: Presented at EASL - (DGDispatch)
    Tenofovir Disoproxil Fumarate Approved in Europe for Treatment of Chronic Hepatitis B - (DGNews)

    News archive

     Recent webcasts/CME - Hepatitis Other
    • Optimizing Treatment for Chronic HBV: New Data on Management Options
    • Nucleoside Analogs Lead to Long-Term Responses in Chronic Hepatitis B
    • The ABC's of Viral Hepatitis
      Chronic Hepatitis B Virus Infection: Review and Update
      Delivering Optimal Care: Prevention, Detection, and Management of Hepatitis B in Asian and Pacific Islander Americans

      Webcasts/CME archive

       Recent cases - Hepatitis Other
        Cholestatic Hepatitis as a Possible New Side-Effect of Oxycodone: A Case Report
        Sustained Virological and Biochemical Responses to Lamivudine and Adefovir Dipivoxil Combination in a Chronic Hepatitis B Infection Despite Mutations Conferring Resistance to Both Drugs
        Nitrofurantoin-Induced Chronic Active Hepatitis in an Elderly Woman
        Drug-Induced Hepatitis Superimposed on the Presence of Anti-SLA Antibody: A Case Report
        Acute Hepatitis Associated with Q Fever in a Man in Greece: A Case Report

        Cases archive
          




        my personal edition > hepatitis other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Hepatitis B Cirrhosis Starts 10 Years Earlier than Hepatitis C Cirrhosis

        A DGReview of :"Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients"
        American Journal of Gastroenterology

        11/29/2002
        By Robert Short


        Patients with hepatitis B infection (HBV) present with cirrhosis about 10 years earlier than patients with hepatitis C (HCV) infection.

        This was one of the conclusions of Dr. Giovanna Fattovich and colleagues, and the European Concerted Action on Viral Hepatitis (EUROHEP). Dr. Fattovich is based at Servizio Autonomo Clinicizzato di Gastroenterologia, University of Verona, Verona, Italy.

        The investigators performed a retrospective cohort study of 297 untreated Western European patients with compensated viral cirrhosis who were followed for a median period of 6.6 years. The aim of the study was to compare the prognosis of patients who were hepatitis B surface antigen positive and those with antibody to HCV.

        It was found that the median age at diagnosis was 48 years in the hepatitis B surface antigen-positive cirrhotic patients and 58 years in the HCV-positive cirrhotic patients. Thus, patients with HBV infection may present with cirrhosis about 10 years earlier than those with HCV infection.

        Dr Fattovich noted, "HCV infection tends to be associated with a higher risk of decompensation, but these data should take into consideration the heterogeneity of HBV-related cirrhosis in terms of viraemia levels and risk of hepatic failure."

        Dr Fattovich added that there were no significant differences in survival according to HBV or HCV aetiology in Western European cirrhotic patients.
        The American Journal of Gastroenterology 2002;97(11):2886-2895. "Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send